Dr. Wong Sean Man Natalie - Clinical Oncology
Specialist in Clinical Oncology
Highlights
- MCHK RegisteredVerified
- Specialist in Clinical OncologyBachelor of Medicine and Bachelor of Surgery (MBBS) · Hong Kong College of Radiologists · Medical degree 2012
- InsuranceBeing compiled｜See details
About
Dr. Wong Sean Man Natalie is a registered Clinical Oncology specialist in Hong Kong.
Education
Specialist in Clinical Oncology
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)2012
Hong Kong Academy of Medicine fellowships
- FHKCRFellow, Hong Kong College of Radiologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Wong Sean Man Natalie? Claim page and update insurance →
FAQ
Is Dr. Wong Sean Man Natalie any good?
Dr. Wong Sean Man Natalie is a registered Clinical Oncology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Wong Sean Man Natalie do?
Dr. Wong Sean Man Natalie practises in Clinical Oncology.
Are you Dr. Wong Sean Man Natalie? Claim this page to update and manage.
ClaimResearch and publications
12 papers
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Compensatory Hypertrophy and Changes of Liver Function After Sequential Transarterial Chemoembolization, Stereotactic Body Radiation Therapy, and Immunotherapy (START-FIT) in Unresectable Hepatocellular Carcinoma.International journal of radiation oncology, biology, physics · 2026
- Early Outcomes of Preoperative Short Course Radiotherapy With Simultaneous Integrated Boost and Response-adapted Chemotherapy for Advanced Rectal Cancer.Clinical oncology (Royal College of Radiologists (Great Britain)) · 2025
- Long-Term Outcome of Stereotactically Designed Hypofractionated Image Guided Radiation Therapy in Large, Unresectable Hepatocellular Carcinoma.Practical radiation oncology · 2025
- Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular Carcinoma.JAMA oncology · 2024
- Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma.Liver cancer · 2024
- Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial.The lancet. Gastroenterology & hepatology · 2023
- Neoadjuvant short-course radiotherapy or chemoradiation plus consolidative chemotherapy followed by radical operation for locally advanced rectal cancer.Frontiers in oncology · 2023
- Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced colorectal cancer.Frontiers in oncology · 2023
- Compassionate Use of Ripretinib for Patients With Metastatic Gastrointestinal Stromal Tumors: Taiwan and Hong Kong Experience.Frontiers in oncology · 2022
- Presence of tumour capsule on contrast-enhanced CT is associated with improved outcomes of stereotactic body radiation therapy in hepatocellular carcinoma patients.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2022
- Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience.Frontiers in oncology · 2022
- Palliative Liver Radiotherapy (RT) for Symptomatic Hepatocellular Carcinoma (HCC).Scientific reports · 2020
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer